It has now been more than nine months since Oracle's report for the first quarter of fiscal 2026 (ended Aug. 31, 2025). At ...
Stonebraker essentially abandoned Postgres in the mid-1990s. But instead of fading into obscurity, the codebase was salvaged ...
Oracle Corp shares declined by the most in six months after the company reported quarterly capital expenses that were higher than estimates, raising investor concerns about the profitability of the AI ...
June 11 (Reuters) - Oracle shares tumbled 12% on Thursday as surging spending and a ballooning debt load fanned investor concerns about the cash burn in the company's push to build out AI ...
MHS Behavioral Services and Restorative Behavioral Health LLC , along with Solutions of Change are collaborating on complimentary community events for June’s Men’s Health Month, including the monthly ...
Oracle (ORCL) stock just had the kind of day that spooks shareholders. Shares of the database and cloud giant tumbled about 9.6% on Friday, June 5, closing at $213.68 after opening near $229. That ...
Add Yahoo as a preferred source to see more of our stories on Google. Otsuka Pharmaceutical presented the 12 month data at ERA 2026. Credit: Piotr Swat/SOPA Images/LightRocket via Getty Images) (Piotr ...
— Strong findings support VOYXACT, the first and only U.S. FDA-approved selective APRIL inhibitor, as an early, targeted therapy that addresses key drivers of disease progression: preserving kidney ...
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that VOYXACT ® (sibeprenlimab-szsi) preserved kidney function compared to ...
Shares of Oracle ( ORCL 5.64%) shot up 39.9% in May, according to data from S&P Global Market Intelligence. After rising to over $300 a share last summer, Oracle's stock tumbled in the ensuing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results